Exosla

Develops extracellular-vesicle immunotherapies for newborns with hypoxic brain injury and other immune-related diseases

Cambridge, United KingdomFounded 2020exosla.com Website technologies

Highlights

New on EvolcAdded 2026-11-13

About Exosla

Exosla Therapeutics develops immunotherapies using extracellular vesicles derived from monoclonal mesenchymal stem/stromal cell lines. Its stated focus includes protecting newborn brains after hypoxic injury and a pipeline for immune-related diseases.

The company is based in Cambridge, United Kingdom, and was founded in 2020. Its leadership and advisors include researchers and clinicians in extracellular-vesicle science, neurology, and cell therapy.

Product: Immunotherapy candidates based on extracellular vesicles derived from monoclonal mesenchymal stem/stromal cell lines.

Jobs at Exosla

No open positions listed right now.

More biotech & pharma companies

Extracellular
CDMO for cell-based food, cosmetics and materials products, offering bioprocess development and up to 2,000L manufacturing
Bristol, United KingdomBiotech & pharmaFounded 20221 open job
Young companySalary transparent
Exymes
Enzyme-based DNA/RNA extraction reagents and kits for forensic, academic, veterinary and environmental labs
Bournemouth, United KingdomBiotech & pharmaFounded 2023
Young company
F2G
Develops medicines for patients with rare, life-threatening fungal infections
Macclesfield, United KingdomBiotech & pharmaFounded 1998
Fabricnano
Enzyme immobilization technology for industrial companies developing cell-free biomanufacturing processes
London, United KingdomBiotech & pharmaFounded 2018
New on Evolc
Fast MDX
Automated molecular diagnostic testing platform for clinical and pathology laboratories
Greenford, United KingdomBiotech & pharmaFounded 1994
New on Evolc
Fibrofind
Human-tissue preclinical drug testing and research services for biopharmaceutical companies and drug developers
Newcastle Upon Tyne, United KingdomBiotech & pharmaFounded 2018
New on Evolc

All biotech & pharma companies →

Website technologies

Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.

Backend

PHPHigh confidence
First detected
13 Nov 2026
Last detected
13 Nov 2026
Last checked
13 Nov 2026
Detection evidence
- Response headerx-powered-by
- Response headerx-powered-by
- Response headerx-powered-by

Content management

WordPressHigh confidence
First detected
13 Nov 2026
Last detected
13 Nov 2026
Last checked
13 Nov 2026
Detection evidence
- Website resourcedeclared script/iframe or software asset

Forms

Contact Form 7High confidence
First detected
13 Nov 2026
Last detected
13 Nov 2026
Last checked
13 Nov 2026
Detection evidence
- Website resourcedeclared script/iframe or software asset
Google reCAPTCHAHigh confidence
First detected
13 Nov 2026
Last detected
13 Nov 2026
Last checked
13 Nov 2026
Detection evidence
- Website resourcedeclared script/iframe or software asset

Frontend frameworks

jQueryHigh confidence
First detected
13 Nov 2026
Last detected
13 Nov 2026
Last checked
13 Nov 2026
Detection evidence
- Website resourcedeclared script/iframe or software asset

Hosting

ApacheHigh confidence
First detected
13 Nov 2026
Last detected
13 Nov 2026
Last checked
13 Nov 2026
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver

Privacy & consent

CookieYesHigh confidence
First detected
13 Nov 2026
Last detected
13 Nov 2026
Last checked
13 Nov 2026
Detection evidence
- Website resourcedeclared script/iframe or software asset

Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.